Search - tctmd.com

Displaying 21 - 40 of 119

Sort: Relevancy | Date

News Daily News

Vascular Disease History Need Not Preclude Aspirin Withdrawal After HeartMate 3

Yael L. Maxwell

January 15, 2025

News Daily News

FDA Approves First ‘Near-Complete’ Stabilizer to Treat ATTR Cardiomyopathy

L.A. McKeown

November 25, 2024

News Conference News AHA 2024

Novel CRISPR-Cas9 Therapy Slows ATTR-CM Progression

Yael L. Maxwell

November 20, 2024

News Conference News AHA 2024

Nasal Bumetanide Safe, Effective in Healthy Adults

Yael L. Maxwell

November 18, 2024

SUMMIT: Tirzepatide ‘Huge Win’ for HFpEF Patients With Obesity

News Conference News AHA 2024

SUMMIT: Tirzepatide a ‘Huge Win’ for HFpEF Patients With Obesity

Michael O'Riordan

November 16, 2024

News Conference News HFSA 2024

Biomarker and Echo Data Bolster Vutrisiran’s Promise in ATTR-CM

L.A. McKeown

October 04, 2024

News Daily News

Yes, Clinical Inertia IS the Leading Cause of GDMT Underuse in HFrEF

Todd Neale

September 20, 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for August 2024

Caitlin E. Cox

September 03, 2024

News Conference News ESC 2024

FINEARTS-HF: Benefit of Finerenone Extends to HFmrEF and HFpEF Patients

Michael O'Riordan

September 01, 2024

News Opinion CV Team Dispatch

August 2024 Dispatch for the CV Team

L.A. McKeown

August 01, 2024

News Daily News

Aligning Pill Burden and Palliative Care Needs in Late-Stage CVD: AHA

L.A. McKeown

July 02, 2024

News Conference News NY Valves 2024

Polymer Mitral Valve Shows Well Early, but Long-term Data Key

Michael O'Riordan

June 12, 2024

News Opinion CV Team Dispatch

June 2024 Dispatch for the CV Team

L.A. McKeown

June 01, 2024

News Conference News ESC Heart Failure 2024

Better Natriuresis With IV Furosemide and Metolazone in Chronic HF Patients

Michael O'Riordan

May 13, 2024

News Daily News

TAVI Outcomes Linked to LV Recovery in Patients With Severe Dysfunction

Michael O'Riordan

May 06, 2024

News Daily News

Statins Might Help in HFpEF—Even in the Absence of ASCVD

Todd Neale

May 01, 2024

News Opinion CV Team Dispatch

May 2024 Dispatch for the CV Team

L.A. McKeown

May 01, 2024

News Conference News ACC 2024

IMPROVE-HCM: Ninerafaxstat May Fill a Niche in Nonobstructive HCM

Caitlin E. Cox

April 15, 2024

News Opinion Off Script

Evoque and Patisiran: A Tale of Two Regulatory Journeys

Sanjay Kaul, MD

March 29, 2024

News Daily News

ACC Updates HFrEF Decision Pathway, Reinforcing the Four Pillars of Therapy

Todd Neale

March 11, 2024

Advertisement

Vascular Disease History Need Not Preclude Aspirin Withdrawal After HeartMate 3

FDA Approves First ‘Near-Complete’ Stabilizer to Treat ATTR Cardiomyopathy

Novel CRISPR-Cas9 Therapy Slows ATTR-CM Progression

Nasal Bumetanide Safe, Effective in Healthy Adults

SUMMIT: Tirzepatide a ‘Huge Win’ for HFpEF Patients With Obesity

Biomarker and Echo Data Bolster Vutrisiran’s Promise in ATTR-CM

Yes, Clinical Inertia IS the Leading Cause of GDMT Underuse in HFrEF

TCTMD’s Top 10 Most Popular Stories for August 2024

FINEARTS-HF: Benefit of Finerenone Extends to HFmrEF and HFpEF Patients

August 2024 Dispatch for the CV Team

Aligning Pill Burden and Palliative Care Needs in Late-Stage CVD: AHA

Polymer Mitral Valve Shows Well Early, but Long-term Data Key

June 2024 Dispatch for the CV Team

Better Natriuresis With IV Furosemide and Metolazone in Chronic HF Patients

TAVI Outcomes Linked to LV Recovery in Patients With Severe Dysfunction

Statins Might Help in HFpEF—Even in the Absence of ASCVD

May 2024 Dispatch for the CV Team

IMPROVE-HCM: Ninerafaxstat May Fill a Niche in Nonobstructive HCM

Evoque and Patisiran: A Tale of Two Regulatory Journeys

ACC Updates HFrEF Decision Pathway, Reinforcing the Four Pillars of Therapy

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content